ArticleBreast care (Basel, Switzerland)2022

First-Line Efficacy of Anti-HER2 Treatments in Previously Treated HER2-Positive Metastatic Breast Cancer Patients: A Retrospective Observational Study Investigating the Efficacy of Re-Exposure to Anti-HER2 Therapy for HER2-Positive Metastatic Breast Cancer Patients in Comparison with Naïve Patients.

Barliz Waissengrin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.